VoxEU Column How to nudge COVID-19 vaccination while respecting autonomous decision making Fumio Ohtake Tomoya Saito Shusaku Sasaki 13 Dec 2021 COVID-19 Vaccination Vaccine Herd immunity vaccine hesitancy Nudges vaccination take-up Covid-19 Covid-19 vaccine
VoxEU Column Heterogeneous firm-level impact of Covid-19 and the role of vaccine developments in recovery expectations Enrique Moral-Benito 26 Aug 2021 COVID-19 Productivity and Innovation Covid-19 Uncertainty firm survey Productivity Vaccine Recovery
Discussion paper DP16324 Could Vaccine Dose Stretching Reduce COVID-19 Deaths? Witold Więcek Amrita Ahuja Michael Kremer Alexandre Simoes Gomes Junior Christopher Snyder Alex Tabarrok Brandon Tan 3 Jul 2021 Vaccine Pandemic Epidemiology Public health Supply chains Development Economics
VoxEU Column From tragedy to hesitancy: How public health failures boosted COVID-19 vaccine scepticism Geraldine Blanchard-Rohner Bruno Caprettini Dominic Rohner Hans-Joachim Voth 1 Jun 2021 Health Economics COVID-19 Coronavirus Covid-19 Healthcare Trust Uk Vaccine vaccine hesitancy
Discussion paper DP15980 The welfare cost of vaccine misallocation, delays and nationalism Christian Gollier 30 Mar 2021 Covid Pandemic Vaccine Anti-vaxxer Covid immunity passport Public Economics
VoxEU Column The value of a vaccine to end COVID-19 is worth between 5% and 15% of wealth Viral Acharya Timothy Johnson Suresh Sundaresan Steven Zheng 19 Jan 2021 COVID-19 Financial Markets Coronavirus Covid-19 Expectations Stock markets Vaccine
Discussion paper DP15558 The Value of a Cure: An Asset Pricing Perspective Viral Acharya Timothy Johnson Suresh Sundaresan Steven Zheng 14 Dec 2020 Pandemic Vaccine Covid-19 Regime-switching Parameter uncertainty Financial Economics Macroeconomics and Growth Public Economics G12 D5 I1 Q54
VoxEU Column Why prudent people might avoid vaccinations Leonard Goebel Thomas Mayrhofer Hendrik Schmitz 12 Dec 2020 COVID-19 Coronavirus Covid-19 Vaccine Risk-aversion Prudence
Discussion paper DP15558 The Value of a Cure: An Asset Pricing Perspective Viral Acharya Timothy Johnson Suresh Sundaresan Steven Zheng 11 Dec 2020 Pandemic Vaccine Covid-19 Rare disasters Regime-switching Parameter uncertainty Financial Economics Macroeconomics and Growth Public Economics G12 D5 I1 Q54
VoxEU Column Vaccine challenges Cevat Giray Aksoy Barry Eichengreen Orkun Saka 16 Nov 2020 COVID-19 Health Economics Covid-19 Vaccine anxi-vaxxers vaccine hesitancy
Discussion paper DP15433 Optimal Subsidies for Prevention of Infectious Disease Michael Kremer Heidi Williams Christopher Snyder Matthew Goodkin-Gold 6 Nov 2020 Vaccine Epidemiology Externality Pharmaceutical Development Economics Industrial Organization O31 L11 I18 D42
VoxEU Column A vaccination policy for green zones Miquel Oliu-Barton Bary Pradelski 2 Oct 2020 COVID-19 Covid-19 Vaccination Vaccine green zones red zones
